Primary information |
---|
sequence ID | Seq_7180 |
Peptide sequence | SHALQLNNR |
CancerPDF_ID | CancerPDF_ID1898, CancerPDF_ID3158, CancerPDF_ID9453, |
PMID | 21136997,21136997,26379225 |
Protein Name | Complement C4-B,Complement C4-A,Complement C4-A/Complement C4-B |
UniprotKB Entry Name | CO4B_HUMAN,CO4A_HUMAN,"CO4A_HUMAN,CO4B_HUMAN" |
Fluid | Serum,Plasma,Plasma |
M/Z | 1051.55229,1051.5523,1052.56 |
Charge | 1,1,NA |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,MALDI-TOF |
Peptide Identification technique | LC-MS-MS/MS,LC-MS-MS/MS,MALDI-TOF/TOF |
Quantification Technique | LC-ESI-MS,LC-ESI-MS,NA |
Labelled/Label Free | Label Free,Label Free,Label Free |
FDR | NA,NA,NA |
CancerPDF_ID | CancerPDF_ID1898, CancerPDF_ID3158, CancerPDF_ID9453, |
p-Value | NA,NA,NA |
Software | MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT (v 2.3) |
Length | 9,9,9 |
Cancer Type | Colorectal cancer,Normal,Colorectal cancer |
Database | SwissProt Database,SwissProt Database,UniprotKB |
Modification | NA,NA,NA |
Number of Patients | 30 patients and 30 healthy controls,27 healthy individuals,"94 patients with CRC, 23 with liver metastasis from CRC (histologically defined) and 34 subjects, which underwent colonoscopy and resulted negative" |
Regulation | NA,NA,"Intensity was similar to controls, controversially, in adenoma and CRC groups was highest. " |
Validation | Leave One out Cross validation,Leave One out Cross validation,NA |
Sensitivity | NA,NA,NA |
Specificity | NA,NA,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |